Prevalence of cryptococcal meningitis at a tertiary care centre in Western India (1996-2005)

Journal of Medical Microbiology

Volumn 55, Issue 9, 2006, Pages 1301-1302

  Satpute, Meena G ^a   Telang, Nilima V ^a   Litake, Geetanjali M ^a   Niphadkar, Krishna B ^a   Joshi, Suresh G ^a,b  

^a KEM HOSPITAL   (India)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FUNGUS ANTIGEN;

ANTIGEN DETECTION; CEREBROSPINAL FLUID ANALYSIS; CRYPTOCOCCUS; FUNGAL MENINGITIS; HUMAN; INDIA; LETTER; PRIORITY JOURNAL; TERTIARY HEALTH CARE;

ANTIGENS, FUNGAL; CRYPTOCOCCUS; HEALTH FACILITIES; HUMANS; INDIA; LATEX FIXATION TESTS; MENINGITIS, CRYPTOCOCCAL; PREVALENCE; RETROSPECTIVE STUDIES;

EID: 33748541984     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.46657-0     Document Type: Letter

References (12)

1. Bekondi, C., Bernede, C., Passone, N., Minssart, P., Kamalo, C., Mbolidi, D. & Germani, Y. (2006). Primary and opportunitistic pathogens associated with meningitis in adults in Bangui, Central African Republic, in relation to human immunodeficiency virus serostatus. Int J Infect Dis (in press; http://dx.doi.org/10.1016/j.ijid.2005.07.004).
2. Chakrabarti, A., Sharma, A., Sood, A., Grover, R., Sakhuja, V., Prabhakar, S. & Verma, S. (2000). Changing scenario of cryptococcosis in a tertiary care hospital in north India. Indian J Med Res 112, 56-60.
3. Cunha, B. A. (2001). Central nervous system infections in the compromised host: a diagnostic approach. Infect Dis Clin North Am 15, 567-590.
4. Gottfredsonn, M. (2000). Fungal meningitis. Semin Neurol 20, 307-322.
5. Hoang, L. M. N., Maguire, J. A., Doyle, P., Fyfe, M. & Roscoe, D. L. (2004). Cryptococcal neoformans infections at Vancouver Hospital and Health Sciences Center (1997-2002): epidemiology, microbiology and histopathology. J Med Microbiol 53, 935-940.
6. Kwon-Chung, K. J., Polacheck, I. & Bennet, J. (1982). Improved diagnostic medium for separation of Cryptococcus neoformans var. neoformans (serotypes A and D) and Cryptococcus neoformans var. gattii (serotypes B and C). J Clin Microbiology 15, 535-537.
7. Lu, H., Zhou, Y., Yin, Y., Pan, X. & Weng, X. (2005). Cryptococcal antigen test revisited: significance for cryptococcal meningitis therapy monitoring in a tertiary Chinese hospital. J Clin Microbiol 43, 2989-2990.
8. Madan, M., Ranjitham, M., Chandrasekharan, S. & Sudhakar (1999). Cryptococcal meningitis in immunocompetent individuals. J Assoc Physicians India 47, 933-934.
9. Padhye, A. A., Chakrabarti, J., Chander, J. & Kaufman, L. (1993). Cryptococcus neoformans var. gattii in India. J Med Vet Mycol 31, 165-168.
10. Shin, C. C., Chen, Y. C., Chang, S. C., Luh, K.-T. & Hsieh, W.-C. (2000). Cryptococcal meningitis in non-HIV-infected patients. Q J Med 93, 245-251.
11. Steenbergen, J. N. & Casadevall, A. (2000). Prevalence of Cryptococcus neoformans var. neoformans (serotype D) and Cryptococcus neoformans var. grubii (serotype A) isolates in New York City. J Clin Microbiol 38, 1974-1176.
12. Warren, N. G. & Hazen, K. C. (1999). Candida, Cryptococcus and other yeasts of medical importance. In Manual of Clinical Microbiology, pp. 1184-1199. Edited by P. R. Murray, E. J. Baren, M. A. Pfaller, F. C. Tenover & R. H. Yolken. Washington DC: American Society for Microbiology.